Outputs

Decision-support, not document dumps.

Outputs are designed for IC memos, term sheet discussions, and follow-up diligence prioritization. They support expert review and decision-making.

  • Acquire / Conditional Acquire / Do Not Acquire recommendation
  • Ranked value killers
  • Ranked upside drivers
  • Cross-domain regulatory risks
  • FDA likely questions
  • Data gaps
  • Confidence scoring
  • Suggested diligence follow-ups
  • Milestone / CVR / option-to-buy considerations
Illustrative output

A sample asset diligence summary.

Cross-domain reasoning across regulatory, clinical, CMC, and deal dimensions — surfaced as ranked signals, not raw documents.

Before the term sheet

Understand the asset risk before you commit capital.

A short conversation is enough to scope a meaningful diligence review, tailored to your asset stage and decision window.

No confidential information required to start the conversation.